Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013 [View article]
Not really. Although after watching the O.J. Simpson debacle, I can certainly understand it happening for Enzo as well... Any opinion on the company's chances? So far, so good with good patent protection thus far..
'Top Of The Class' Small Pharma Investments For 2013 [View article]
Nice sir! I wish ADMD would have worked out better for you! Moving forward, I think ACRX still has some upside left in it, although the risk/reward isn't as big as it was. APRI is beasting after unfounded rumors of takeover just because they removed a "poison pill" from its shareholder rights agreement. I am a bit concerned with the delay in the Canadian launch and give the EU approval a 50/50 chance. ADMD is stuck right around where it is until it provides some meaningful news/revenue, although I don't think there is much downside from here and is worth a hold IMO. Good luck moving ahead and remember that there is nothing wrong with securing gains from a big winner, while you can afford to wait for the laggards to move up and increase your overall profits... :) Best of luck sir and congrats on a good run so far!
"Paul Nouri - Noble Equity Funds Have you gotten court dates with any of the other cases yet? Barry W. Weiner - Co Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director Yes, we have. We are looking to court dates in early November for the New York cases."
"Paul Nouri - Noble Equity Funds Looking at the Life Technologies court decision, I guess the timing of it becoming finalized is the next 6 to 9 months at this point?"
I think that's it? May have to dig a little for the other (I wrote this a couple of weeks ago). Thanks.
2 Medical Device Companies With Revolutionary Platforms [View article]
Hi Curtis, and I appreciate you stopping by. I'm actually much better versed with the technologies and technical analysis and need to study up on the warrants, especially as pertaining to the warrants call PR. I'm betting on some fairly impressive data from the first 1-3 patients early in the trial which could give the company a little leverage when looking for financing. I'll post if I can find anything particularly useful... Take care sir!
Imminent Catalysts For Small Pharmaceuticals [View article]
Agreed. Especially if an independent data monitoring committee is utilized to review data. With Inovio's phase 2 trials I believe it is up to the company's discretion until final data is compiled?
Imminent Catalysts For Small Pharmaceuticals [View article]
Actually, I'm not certain. I'm certain there are some SEC rules about matters of "material importance", particularly if the data were bad? Just conjecture... Anybody else?
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
Agreed JSF. As I commented above, I feel there are many watching from the sidelines that aren't quite convinced yet. I will add half a position on any weakness, and then the remainder once/if data prove to be promising. Thanks and good luck to you.
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
Agreed on all points and I appreciate the compliments. I would love to visit Inovio or one of the clinical sites to watch the treatment in person. I believe that could be very revealing.... Please don't be a stranger!
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
Thanks Joe. I believe there are a great many people with INO on their watch lists due to its large targeted market group, but they're awaiting more solid proof of efficacy before jumping in... Actually, I don't yet have a position either, but will likely open one this week as I'm a bargain shopper and usually don't buy on a gap up kind of day like today... Good luck ahead Joe!
Biodel: Reemerging From Obscurity In 2013 [View article]
My recollection is that Biodel abandoned the sublingual glucagon, but is still developing the heat stable (room temperature) solution version. I guess the "stable" sublingual formulation is the one that the Q1 2014 NDA was referencing? Anyway, updates on the heat stable solution should be forthcoming as noted above "We will provide you with updates on our progress and projected development timelines in subsequent calls" in the February 12th CC.
Thanks for the clarification and please have a nice weekend ahead. CF
Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013 [View article]
'Top Of The Class' Small Pharma Investments For 2013 [View article]
Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013 [View article]
http://seekingalpha.co...
"Paul Nouri - Noble Equity Funds
Have you gotten court dates with any of the other cases yet?
Barry W. Weiner - Co Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director
Yes, we have. We are looking to court dates in early November for the New York cases."
"Paul Nouri - Noble Equity Funds
Looking at the Life Technologies court decision, I guess the timing of it becoming finalized is the next 6 to 9 months at this point?"
I think that's it? May have to dig a little for the other (I wrote this a couple of weeks ago). Thanks.
2 Medical Device Companies With Revolutionary Platforms [View article]
Imminent Catalysts For Small Pharmaceuticals [View article]
Imminent Catalysts For Small Pharmaceuticals [View article]
Detecting Investment Potential In Medical Diagnostics Companies [View article]
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
Thanks and best of luck this week!
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
CF
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 [View article]
CF
Apricus Biosciences: A Transformative Year Ahead [View article]
Thanks
Biodel: Reemerging From Obscurity In 2013 [View article]
Thanks for the clarification and please have a nice weekend ahead.
CF
Small Pharma Watch List: Week Of April 8, 2013 [View article]
http://bit.ly/10RylPc